Rhythm Pharmaceuticals Cash from Investing (TTM) Insights

Rhythm Pharmaceuticals Inc (RYTM)

38.70 +0.55 (+1.44%) USD | NASDAQ | Apr 26, 13:24

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2017. Upgrade now.

Date	Value
December 31, 2023	-5.665M
September 30, 2023	-69.08M
June 30, 2023	-13.82M
March 31, 2023	-26.03M
December 31, 2022	28.03M
September 30, 2022	76.05M
June 30, 2022	178.53M
March 31, 2022	156.08M
December 31, 2021	-62.16M
September 30, 2021	-7.52M
June 30, 2021	-35.39M
March 31, 2021	-16.05M
December 31, 2020	158.53M

Date	Value
September 30, 2020	-42.48M
June 30, 2020	-35.92M
March 31, 2020	-22.64M
December 31, 2019	-27.97M
September 30, 2019	123.43M
June 30, 2019	-54.51M
March 31, 2019	-84.21M
December 31, 2018	-87.15M
September 30, 2018	-210.87M
June 30, 2018	-67.96M
March 31, 2018	-81.42M
December 31, 2017	-110.04M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-69.08M

Minimum

Sep 2023

178.53M

Maximum

Jun 2022

15.86M

Average

-16.05M

Median

Mar 2021

Cash from Investing (TTM) Benchmarks